BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 6347577)

  • 1. Urinary excretion of N-acetyl-beta-D-glucosaminidase in children with type I diabetes mellitus.
    Ellis EN; Brouhard BH; Lagrone L; Travis LB
    Diabetes Care; 1983; 6(3):251-5. PubMed ID: 6347577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of exercise on urinary N-acetyl-beta-D-glucosaminidase activity and albumin excretion in children with type I diabetes mellitus.
    Brouhard BH; Allen K; Sapire D; Travis LB
    Diabetes Care; 1985; 8(5):466-72. PubMed ID: 4053933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between urinary activity of N-acetyl-beta-D-glucosaminidase (NAG) and albumin excretion rate in type II (non-insulin-dependent) diabetic subjects.
    Perdichizzi G; Cucinotta D; Fera R; Di Cesare E; Campo S; Squadrito G
    Acta Diabetol Lat; 1987; 24(2):149-55. PubMed ID: 3115019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of urinary N-acetyl-beta-D-glucosaminidase to rapid decreases in blood glucose.
    Brouhard BH; LaGrone L; Travis LB; Pollard TG
    Clin Chim Acta; 1984 Jul; 140(2):197-202. PubMed ID: 6467609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary N-acetyl-beta-D-glucosaminidase activity in children with insulin-dependent diabetes mellitus.
    Hsiao PH; Tsai WS; Tsai WY; Lee JS; Tsau YK; Chen CH
    Am J Nephrol; 1996; 16(4):300-3. PubMed ID: 8739282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased urinary N-acetyl-beta-glucosaminidase (NAG) excretion in young insulin-dependent diabetic patients.
    Lorini R; Scaramuzza A; Cortona L; Valenti G; d'Annunzio G; Melzi d'Eril GV
    Diabetes Res Clin Pract; 1995 Aug; 29(2):99-105. PubMed ID: 8591705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary N-acetyl-beta-D-glucosaminidase excretion in insulin-dependent diabetes mellitus: relation to microalbuminuria, retinopathy and glycaemic control.
    Watts GF; Vlitos MA; Morris RW; Price RG
    Diabete Metab; 1988; 14(5):653-8. PubMed ID: 3234588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of hyperfiltration on the measurement of urinary N-acetyl-beta-D-glucosaminidase.
    Müller D; Sievers E; Eggert P
    Pediatr Nephrol; 1999 Aug; 13(6):519-23. PubMed ID: 10452282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary N-acetyl-beta-D-glucosaminidase activity does not predict development of diabetic nephropathy.
    Agardh CD; Tallroth G; Hultberg B
    Diabetes Care; 1987; 10(5):604-6. PubMed ID: 3677979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary N-acetyl-beta-D-glucosaminidase activity in type I diabetes mellitus.
    Mungan N; Yuksel B; Bakman M; Topaloglu AK; Ozer G
    Indian Pediatr; 2003 May; 40(5):410-4. PubMed ID: 12768043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary N-acetyl-beta-D-glucosaminidase in streptozotocin-induced diabetic rats.
    Ellis EN; Brouhard BH; LaGrone L
    Biochem Med; 1984 Jun; 31(3):303-10. PubMed ID: 6477535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal tubular proteinuria and microalbuminuria in diabetic patients.
    Gibb DM; Tomlinson PA; Dalton NR; Turner C; Shah V; Barratt TM
    Arch Dis Child; 1989 Jan; 64(1):129-34. PubMed ID: 2923463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of urinary N-acetyl-beta-D-glucosaminidase as a marker of early renal damage in patients with type 2 diabetes mellitus.
    Bouvet BR; Paparella CV; Arriaga SM; Monje AL; Amarilla AM; Almará AM
    Arq Bras Endocrinol Metabol; 2014 Nov; 58(8):798-801. PubMed ID: 25465599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between the Urinary N-acetyl-β-D-Glucosaminidase/Creatinine Ratio and Factors of the Metabolic Syndrome.
    Lee E; Lee YK; Kang HJ
    Ann Clin Lab Sci; 2018 Sep; 48(5):627-633. PubMed ID: 30373868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin reduces urinary excretion of N-acetyl-beta-D-glucosaminidase, albumin and renal oxidative markers in diabetic rats.
    Oktem F; Ozguner F; Yilmaz HR; Uz E; Dündar B
    Clin Exp Pharmacol Physiol; 2006; 33(1-2):95-101. PubMed ID: 16445706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 24 h-urinary excretions of albumin, beta 2-microglobulin and N-acetyl-beta-D-glucosaminidase activity in children with IDDM.
    Hosoi H; Asakura Y; Irie M; Hataya N; Tsunoda M; Ohki Y; Mineda T; Teshirogi T
    Nihon Ika Daigaku Zasshi; 1989 Jun; 56(3):241-4. PubMed ID: 2666432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary Lysosomal Enzyme Activities and Albuminuria in Ghanaian Patients with Type 2 Diabetes Mellitus.
    Asare-Anane H; Twum F; Kwaku Ofori E; Torgbor EL; Amanquah SD; Osafo C
    Dis Markers; 2016; 2016():2810639. PubMed ID: 27594733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The excretion of N-acetyl-beta-D-glucosaminidase in the urine of children with urinary tract diseases].
    Zandvliet EE; Giesberts MA; van Gelderen HH
    Tijdschr Kindergeneeskd; 1983 Aug; 51(4):135-8. PubMed ID: 6670088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The renal tubular damage marker urinary N-acetyl-β-D-glucosaminidase may be more closely associated with early detection of atherosclerosis than the glomerular damage marker albuminuria in patients with type 2 diabetes.
    Kim SR; Lee YH; Lee SG; Kang ES; Cha BS; Lee BW
    Cardiovasc Diabetol; 2017 Jan; 16(1):16. PubMed ID: 28122570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary N-acetyl-β-D-glucosaminidase, an early marker of diabetic kidney disease, might reflect glucose excursion in patients with type 2 diabetes.
    Kim SR; Lee YH; Lee SG; Kang ES; Cha BS; Kim JH; Lee BW
    Medicine (Baltimore); 2016 Jul; 95(27):e4114. PubMed ID: 27399115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.